BEIJING, May 28, 2025 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it will hold its annual general meeting of shareholders (the “AGM”) at Building A, No. 18 Kechuang 11 Street, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing 101111, People’s Republic of China, on June 20, 2025 at 3:00 p.m. (Hong Kong time). No proposal will be submitted for shareholder approval at the AGM. Instead, the AGM will serve as an open forum for shareholders of record to discuss Company affairs with management. Holders of record of Class A ordinary shares and Class B ordinary shares of the Company at the close of business on May 27, 2025 (Hong Kong time) are entitled...

Paris, 28 May 2025 – Conditions for availability or consultation of information relating to the Combined Shareholders’ Meeting of 19 June 2025 The Combined Shareholders’ Meeting of Tarkett will take place on Thursday 19 June 2025 at 9:30 a.m. at the Auditorium located on the ground floor of the Company’s head office (Tour Initiale – 1, Terrasse Bellini – 92919 Paris La Défense). The preliminary notice of meeting serving as convening notice, including the agenda and the draft resolutions, was published in the French Bulletin des Annonces Légales Obligatoires (BALO) Nr. 58 of 14 May 2025. The notice of meeting will be published in the French legal newspaper Le Publicateur Légal on 03 June 2025. Information on how to attend and vote at the Shareholders’ Meeting is included in these notices, as well as in the Notice of meeting brochure available...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab) and an additional early-stage undisclosed biosimilar candidateREYKJAVIK, ICELAND and LONDON, UK (May 28, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into an agreement to expand their commercial partnership to cover three additional biosimilar candidates. The new agreement covers the supply...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab) and an additional early-stage undisclosed biosimilar candidateREYKJAVIK, Iceland and LONDON, May 28, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into an agreement to expand their commercial partnership to cover three additional biosimilar candidates. The new agreement...

Company announcement Management changes in the Nykredit GroupIn connection with Spar Nord Bank A/S becoming part of the Nykredit Group, changes are expected to be made to the boards of directors and executive managements of the companies in the Nykredit Group. Lasse Nyby to become Deputy Chairman of Nykredit A/S and Nykredit Realkredit A/SOn Monday, 2 June, 2025, a general meeting in Nykredit Realkredit A/S is expected to be convened, to be held on 24 June, 2025, at which it is proposed that Lasse Nyby – the current CEO of Spar Nord Bank A/S – joins the Board of Directors of Nykredit Realkredit A/S. Lasse Nyby will continue on the Board of Directors of Nykredit A/S, which he has been a member of since 2007. Lasse Nyby is expected to be appointed Deputy Chairman of the two boards at the following board meetings. Preben Sunke will...

Company announcement Management changes in the Nykredit GroupIn connection with Spar Nord Bank A/S becoming part of the Nykredit Group, changes are expected to be made to the boards of directors and executive managements of the companies in the Nykredit Group. Lasse Nyby to become Deputy Chairman of Nykredit A/S and Nykredit Realkredit A/SOn Monday, 2 June, 2025, a general meeting in Nykredit Realkredit A/S is expected to be convened, to be held on 24 June, 2025, at which it is proposed that Lasse Nyby – the current CEO of Spar Nord Bank A/S – joins the Board of Directors of Nykredit Realkredit A/S. Lasse Nyby will continue on the Board of Directors of Nykredit A/S, which he has been a member of since 2007. Lasse Nyby is expected to be appointed Deputy Chairman of the two boards at the following board meetings. Preben Sunke will...

Company announcement no. 17Management changes in Spar Nord Bank A/SAgreements have been reached regarding the step down of Lasse Nyby and John Lundsgaard In continuation of the completed voluntary takeover offer from Nykredit Realkredit A/S (Nykredit), whereby Nykredit acquired the majority shareholding in Spar Nord Bank A/S (Spar Nord), agreements have been entered into with the board of directors of Spar Nord, whereby Lasse Nyby will resign as CEO of Spar Nord and John Lundsgaard as managing director of Spar Nord. Lasse Nyby and John Lundsgaard will both resign from Spar Nord’s executive board no later than on 30 June 2025. Kjeld Johannesen, chairman of Spar Nord’s board of directors, says: “The agreed resignation is a natural extension of Nykredit’s acquisition of the majority shareholding in Spar Nord...

Allschwil, Switzerland – May 28, 2025At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted convincingly in favor of all proposals by the Board of Directors. The meeting was attended by 166 shareholders, representing a total of 97’748’740 shares, or 43.28% of the total outstanding shares. Led by the Chairman of the Board, Jean-Paul Clozel the company presented a business update. Jean-Paul Clozel, MD, Chairman of the Board of Directors, commented:“On behalf of the Board, I would like to thank the shareholders for their support and loyalty. I strongly believe that with their backing, with our products and pipeline, and with our people working to ramp-up the sales of QUVIVIQ and activate the pipeline, Idorsia can become one of the most successful biotech companies in Europe.” The...

Today, the Chairman of the Board and the CEO of Kvika banki hf. received a letter from Íslandsbanki hf. requesting to enter into merger discussions. The Board of Directors of Kvika banki hf. will review the matter and determine the bank’s next steps. Please note that this notice is a disclosure of inside information per article 7 of regulation (EU) No 596/2014 on market abuse (“MAR”), which is implemented into Icelandic law with the act on measures against market abuse No 60/2021.

Press Release Supporting Nickel Downstream Industry in Indonesia, Danantara Indonesia and INA Announce Strategic Partnership with Eramet Jakarta, 28 May 2025 – The Indonesia Investment Management Agency, Danantara Indonesia, and the Indonesia Investment Authority (INA) announced the signing of a Memorandum of Understanding (MoU) with French mining company Eramet to explore the establishment of a strategic investment platform in the nickel sector, spanning upstream to downstream operations. The signing was witnessed in person by the President of the Republic of Indonesia Prabowo Subianto, and the President of France Emmanuel Macron, at the State Palace in Jakarta on Wednesday (28/052025). This partnership aims to develop a sustainable and integrated electric vehicle (EV) battery raw materials ecosystem in Indonesia. The parties will conduct...